SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$1.14
-0.02 (-1.72%)
Open$1.15
Previous Close$1.16
Day High$1.20
Day Low$1.13
52W High$6.92
52W Low$0.85
Volume—
Avg Volume200.3K
Market Cap5.50M
P/E Ratio—
EPS$-2.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,034.2% upside
Current
$1.14
$1.14
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.10M | 52.88M | 1.82M |
| Net Income | -13,331,805 | -11,514,994 | 463.1K |
| Profit Margin | -24.2% | -23.0% | 25.4% |
| EBITDA | -13,774,970 | -12,558,753 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +4.2% | +4.2% | -7.1% |
| Debt/Equity | 0.05 | 0.05 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |